Topiramate Tablet, Film Coated
Product Images NDC 47335-712

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 47335-712). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

100mg (100mg)

Topiramate Tablets USP 100 mg film-coated tablets label. The label indicates the product is prescription only, contains 60 tablets, and is labeled by Sun Pharmaceutical Industries, Inc. The label includes a barcode and directs pharmacists to dispense with a medication guide for patients.*

FDA Label Image

200mg (200mg)

Label for Topiramate Tablets USP 200 mg, brown-colored, film-coated, circular tablets with debossed S and 712. The label includes dosage storage instructions, pharmacist dispensing guidance, and product identification text. Distributed by Sun Pharmaceutical Industries, Inc., manufactured by Sun Pharmaceutical Industries Limited. Contains 60 tablets per container with an NDC of 47335-712-86.*

FDA Label Image

25mg (25mg)

Label for Topiramate Tablets, USP 25 mg film-coated tablets. The label indicates a quantity of 60 tablets and notes 'Rx only.' It includes a barcode and the Sun Pharmaceutical Industries, Inc. logo and name. The label also instructs pharmacists to dispense with a medication guide.*

FDA Label Image

50mg (50mg)

Topiramate Tablets USP 50 mg film-coated tablets label from Sun Pharmaceutical Industries, Inc. The label includes the NDC code 47335-710-86, states 'Rx only' with a quantity of 60 tablets, and instructs pharmacists to dispense with a medication guide.*

FDA Label Image

Chemical-structure (Chemical Structure)

Chemical structure of Topiramate, showing its molecular framework with multiple rings and functional groups including sulfonamide and methyl substitutions.*

FDA Label Image

Figure-1jpg (Figure 1)

A Kaplan-Meier curve chart showing cumulative rates for time to first seizure over 500 days. The graph compares two groups receiving Topiramate at doses of 50 mg/day and 400 mg/day, with cumulative seizure rates increasing over time. The chart includes a significance value (p = 0.0002).*

FDA Label Image

Figure-2 (Figure 2)

A bar chart depicting the change from baseline to double-blind phase in average monthly migraine period rate for placebo and Topiramate at 50 mg/day, 100 mg/day, and 200 mg/day doses. Data are compared from two studies (Study 11 and Study 12), with statistical significance indicated for the 100 mg/day and 200 mg/day doses, showing greater reductions compared to placebo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.